相关实验视频
Updated: Jun 22, 2025

Investigating Intestinal Inflammation in DSS-induced Model of IBD
Published on: February 1, 2012
开发和研究一种非侵入性疾病严重性指数,用于炎症性肠病
Akhilesh Swaminathan1,2, Grace Mary Borichevsky3, Chris Frampton1
1Department of Medicine, University of Otago Christchurch, Christchurch, New Zealand.
新的非侵入性炎症性肠病 (IBD) 评分,DSI-fCal和DSI-fMPO,准确预测疾病严重程度和未来的并发症,消除了侵入性内镜手术的需要.
科学领域:
- 胃肠病学 胃肠病学
- 临床生物标志物 临床生物标志物
- 炎症性肠道疾病研究研究
背景情况:
- 传统的疾病严重性指数 (DSI) 对于炎症性肠病 (IBD) 需要进行侵入性内镜评估.
- 需要使用非侵入性方法来准确地衡量IBD负担并预测疾病的进展.
研究的目的:
- 开发和验证使用便生物标志物的非侵入性疾病严重性指数得分:DSI-fCal (便calprotectin) 和DSI-fMPO (便髓氧化酶).
- 评估这些非侵入性评分在预测IBD缓解和长期疾病并发症方面的有用性.
主要方法:
- 预期招募成年IBD患者.
- 基于基线生物标志物度的DSI-fCal和DSI-fMPO的开发.
- 与原始DSI的相关性分析,内镜活动,症状和生活质量.
- 接收器运行特征 (AUROC) 和多变量逻辑回归以评估缓解和复杂疾病过程的预测性表现.
主要成果:
- DSI-fCal和DSI-fMPO与原来的DSI,内镜指数,IBD症状和生活质量有很强的相关性.
- 这两种非侵入性评分都准确地预测了六个月后的临床和生化缓解 (AUROC 0.79-0.80).
- DSI-fCal和DSI-fMPO在24个月内预测复杂IBD过程时,表现与原来的DSI相似 (AUROC 0.80-0.83).
结论:
- 非侵入性DSI-fCal和DSI-fMPO得分有效预测IBD患者的纵向疾病过程.
- 这些基于便生物标志物的评分为监测IBD的内镜评估提供了有价值的替代方案.
- 经过验证的非侵入性评分可以帮助预测和管理IBD并发症.
更多相关视频
09:11Systematic Scoring Analysis for Intestinal Inflammation in a Murine Dextran Sodium Sulfate-Induced Colitis Model
Published on: February 14, 2021
09:01Non-invasive Assessment of the Efficacy of New Therapeutics for Intestinal Pathologies Using Serial Endoscopic Imaging of Live Mice
Published on: March 10, 2015
相关概念视频
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Inflammatory Bowel Disease II: Crohn's Disease
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
Inflammatory Bowel Disease I: Ulcerative Colitis
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Chronic Bowel Disorders: Introduction
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation
Irritable Bowel Syndrome (IBS) is classified into subtypes based on the predominant bowel habits as determined by the Bristol Stool Form Scale (BSFS). The subtypes are:
Inflammatory Bowel Disease IV: Pharmacological Management
Pharmacologic...